Oocyte Cryopreservation: What Ovarian Cancer Patients Need to Know About Egg Freezing

Oocyte cryopreservation — more commonly known as egg freezing — is one of the most powerful fertility preservation tools available to women diagnosed with ovarian cancer. 

If you’ve recently received a diagnosis and haven’t yet started treatment, it may feel like every decision is being made for you. Preserving your eggs is one decision you can make for yourself, and it could matter enormously later on.

This guide covers what the procedure involves, why it matters specifically for women with ovarian cancer, what to realistically expect, and the practical details around cost and risk.

What Is Oocyte Cryopreservation?

Oocyte cryopreservation is the process of extracting a woman’s eggs, freezing them at subzero temperatures, and storing them for future use. 

When you’re ready to try for a pregnancy, the frozen eggs are thawed and fertilized through intracytoplasmic sperm injection (ICSI): a process where a single sperm is injected directly into each egg. Any resulting embryos are then transferred to the uterus.

The first human birth from a previously frozen egg was reported in 1986. Since then, the technology has advanced considerably. In 2012, the American Society for Reproductive Medicine (ASRM) removed the “experimental” label from the procedure for women with a medical need, citing comparable success rates to IVF with fresh eggs.  

The key breakthrough was vitrification: a rapid flash-freezing technique that cools eggs almost instantly to –196°C, preventing the formation of ice crystals that would otherwise damage the cell. Eggs frozen using vitrification have survival, fertilization, and pregnancy rates that are now considered comparable to fresh eggs when used in IVF cycles. 

Why Do Women Freeze Their Eggs After an Ovarian Cancer Diagnosis?

Here’s the honest reality: ovarian cancer and the treatments used to fight it — surgery, chemotherapy, and sometimes radiation — can significantly compromise your fertility.

For women with early-stage disease, fertility-sparing surgery may be possible, meaning only the affected ovary is removed while the other is preserved. But even then, chemotherapy can damage the eggs remaining in that healthy ovary. 

Certain drugs, particularly alkylating agents (including platinum-based drugs like carboplatin, which is a cornerstone of ovarian cancer chemotherapy), are especially toxic to ovarian tissue. Research indicates that high-risk chemotherapy regimens carry more than an 80% likelihood of causing permanent disruption to ovarian function.  

For women facing bilateral removal of both ovaries, oocyte cryopreservation becomes impossible after surgery, which is exactly why timing matters so much.

It’s also worth understanding that ovarian cancer doesn’t only affect older women. While it’s commonly diagnosed after menopause, a meaningful share of patients are still in their reproductive years when they receive the news. For those with low-grade serous ovarian cancer, the median age at diagnosis is around 45, with some patients even being diagnosed in their 20s or 30s.

Fertility preservation is not a niche concern for this community. It’s a very real part of the conversation.

Beyond the biological case, there’s an emotional one. Knowing that fertility options were preserved gave back a sense of control in a situation where so much felt out of their hands. That psychological element — the preservation of choice — is real and worth taking seriously.

Who Is a Good Candidate?

Not every ovarian cancer patient will be a candidate for oocyte cryopreservation, and the decision needs to involve your oncologist and a reproductive specialist working together.

You may be a candidate if:

• You have unilateral disease (cancer affecting only one ovary)
• You have been diagnosed with a borderline ovarian tumor (BOT), LGSOC, or early-stage epithelial ovarian cancer
• You have a germ cell tumor, mucinous tumor, or malignant sex-cord stromal tumor (including granulosa cell tumors)
• You have apparent early-stage disease where NCCN guidelines support a unilateral or bilateral salpingo-oophorectomy (USO or BSO) with uterine preservation — an option that may apply across several low-risk or early-stage tumor types for patients who wish to preserve fertility
• Your treatment timeline allows for a 10 to 14-day delay before starting chemotherapy

You may not be a candidate:

• If you need to begin treatment urgently
• If both ovaries must be removed immediately
• If your body has too few remaining eggs for the stimulation medications to work effectively

One important caveat worth raising: the hormone injections used during egg freezing cause estrogen levels to rise significantly, and there is a legitimate clinical concern about whether this could accelerate tumor growth in hormone-sensitive cancers, which may include certain LGSOC and granulosa cell tumors. 

This is not a reason to automatically rule out egg freezing, but it is a conversation that needs to happen between you, your gynecologic oncologist, and a Reproductive Endocrinology and Infertility (REI) specialist before proceeding. The answer depends on your specific diagnosis, tumor biology, and treatment plan.

The Oocyte Cryopreservation Procedure: Step by Step

The process typically takes 10 to 14 days from start to finish: roughly one half of a menstrual cycle. Here’s what it involves:

• Baseline assessment: Before stimulation begins, your fertility specialist will order a pelvic ultrasound and blood tests to evaluate your ovarian reserve. This includes measuring your AMH (anti-Müllerian hormone) level, which gives a reliable estimate of how many eggs you’re likely to produce. They usually also check basal FSH (follicle-stimulating hormone) and estradiol.
• Ovarian stimulation: You’ll self-inject hormone medications daily for approximately 10 to 14 days. These gonadotropins encourage your ovaries to develop multiple follicles simultaneously rather than the single egg your body normally matures each cycle. During this time, you’ll also have several monitoring appointments — ultrasounds and blood draws — to track how your follicles are responding and adjust medication doses if needed.
• Trigger shot: Once the follicles reach the right size (typically 18mm or larger), you receive a final injection to trigger the final maturation of the eggs. Retrieval takes place approximately 36 hours later.
• Egg retrieval: This is a short outpatient procedure, usually 20 to 30 minutes, performed under sedation. A thin needle is guided through the vaginal wall using ultrasound imaging to aspirate the fluid and eggs from each follicle. Most patients go home the same day. Mild cramping and bloating for a day or two afterward are normal.
• Vitrification and storage: The embryologist identifies mature eggs under a microscope. Mature eggs (called metaphase II oocytes) are immediately vitrified and stored in liquid nitrogen. Your clinic will confirm how many eggs were successfully collected and frozen.

When you’re ready to pursue pregnancy, the frozen eggs are thawed, fertilized via intracytoplasmic sperm injection (ICSI) — where a single sperm is injected directly into the egg — and any resulting embryos are transferred to the uterus.

How Many Eggs Do You Need?

This is one of the most common questions, and it doesn’t have a single answer. 

Age at the time of freezing matters enormously. The younger you are, the fewer eggs you need frozen to have a reasonable chance of a future live birth, and the more eggs each stimulation cycle is likely to produce. By the late 30s, both the quantity and quality of eggs decline significantly, meaning more cycles may be needed to bank enough eggs for a realistic shot at pregnancy.

Research gives us some useful benchmarks. According to one review, to achieve a 70% chance of at least one live birth, women aged 30 to 34 would need approximately 14 mature eggs frozen; women aged 35 to 37 would need around 15; and women aged 38 to 40 would need as many as 26 mature eggs.

For ovarian cancer patients, it may only be possible to complete one stimulation cycle before treatment begins, which is why understanding these numbers early matters. Your REI specialist will help set realistic expectations based on your age and ovarian reserve.

Success Rates: What the Research Says

Success rates depend on age at the time of freezing and the number of eggs stored. 

According to research, the estimated efficiency from a vitrified egg to a live-born child is approximately 6.5% per egg overall, ranging from about 5.2% for women 38 and older to 7.4% for women under 30.

Freezing 10 to 15 eggs before age 35 is generally associated with a 70 to 80% estimated chance of achieving at least one future pregnancy.

Around 90% of vitrified eggs survive the thawing process, and approximately 75 to 80% of those that survive can be successfully fertilized. 

These figures represent a significant improvement over the slow-freezing methods used in earlier decades, and they apply to medically indicated freezing (including for cancer patients) as well as elective freezing.

Importantly, studies comparing births from frozen eggs to those from fresh eggs have not shown an increased risk of birth defects or chromosomal abnormalities.

Timing: Before or After Chemotherapy?

The short answer: before, whenever medically possible.

Chemotherapy drugs are toxic to eggs. The damage is difficult to predict, and waiting until after treatment significantly reduces both the quantity and quality of eggs available for retrieval. 

Animal studies have also shown increased rates of miscarriage and fetal abnormality in pregnancies from oocytes exposed to chemotherapy, though large human population studies have not shown the same risk to children born after a waiting period post-treatment.

If egg retrieval after chemotherapy is your only option — because treatment needed to begin urgently — it’s worth discussing with your oncologist and fertility specialist. It is sometimes still possible, particularly during treatment-free intervals, though outcomes are generally less favorable.

Many oncology and fertility teams work closely together to coordinate timing. A single stimulation cycle typically adds no more than two weeks before chemotherapy begins, and research in breast cancer patients (the most studied group) suggests this delay does not appear to impact cancer treatment outcomes.  

Oocyte Cryopreservation: Risks and Side Effects

Oocyte cryopreservation is considered safe, but it’s not without risk. The most significant concern is ovarian hyperstimulation syndrome (OHSS), a condition in which the ovaries become enlarged and fluid accumulates in the abdomen.

Mild OHSS is relatively common and may cause bloating, nausea, and abdominal discomfort. Moderate and severe forms are much less frequent, occurring in fewer than 5% of IVF cycles. Severe OHSS requires careful monitoring and, in rare cases, hospitalization.

It’s worth noting that the GnRH agonist trigger shot is increasingly being used in place of the traditional hCG trigger, as it has been shown to significantly reduce the risk of severe OHSS: something worth discussing with your REI specialist when planning your cycle.

Other potential risks include:

• Ovarian torsion (the ovary twisting on itself; rare, under 0.2%)
• Minor bleeding or infection from the egg retrieval procedure (complication rate under 1%)
• Emotional side effects from hormone fluctuations during stimulation, including mood swings and fatigue

For ovarian cancer patients specifically, there is an additional consideration: transvaginal oocyte retrieval carries a small risk of capsule rupture and cancer cell spillage, which your oncologist and reproductive specialist will weigh carefully before proceeding.

Cost and Insurance Coverage

The financial picture is complicated, and it’s important to go in with clear expectations.

In the United States, a single oocyte cryopreservation cycle costs approximately $10,000 to $15,000 on average, including medications. Annual storage fees typically run between $300 to $600 per year.

Insurance coverage has improved but remains inconsistent. A few U.S. states have mandates requiring coverage of fertility preservation for patients facing medically necessary but potentially gonadotoxic therapies. If you live in one of those states and your cancer treatment qualifies, your insurer may be required to cover part or all of the process. It’s worth verifying your state’s requirements with your insurance provider directly.

For those facing financial barriers, several nonprofit organizations offer grants and financial assistance specifically for cancer patients pursuing fertility preservation. Livestrong Fertility and Fertility Within Reach are two well-known programs. Many fertility clinics also offer discounted rates to patients beginning cancer treatment, so be sure to ask about this early.

Other Fertility Preservation Options

Egg freezing is the most established fertility preservation method for women who don’t have a partner or who don’t wish to create embryos. But it’s not the only option.

Embryo cryopreservation (freezing fertilized eggs as embryos) has the longest track record and carries the strongest effectiveness data of any fertility preservation method. Both embryo and oocyte cryopreservation are considered established, first-line options per ASCO 2025 guidelines. If you have a partner or are open to donor sperm, embryo freezing may be worth discussing with your REI specialist as part of your overall plan.

Ovarian tissue cryopreservation is a surgical option in which ovarian tissue is removed and frozen for later reimplantation. It’s particularly relevant for prepubertal girls and women who don’t have time for ovarian stimulation. For ovarian cancer patients, however, it carries additional complexity because of the risk of reimplanting cancerous cells, so it remains an approach that requires careful specialist evaluation.

Your fertility specialist will help you understand which options are realistic given your cancer type, stage, and treatment timeline.

Frequently Asked Questions

Can I freeze my eggs if I need surgery soon? It depends on your timeline. A stimulation cycle takes 10 to 14 days. If your surgery or chemotherapy can be safely delayed by that window, egg freezing before treatment is generally recommended. Your oncologist and reproductive specialist will coordinate to determine whether this is possible.

Will egg freezing delay my cancer treatment? In most cases, a single cycle adds a two-week delay. Studies in breast cancer patients suggest this does not negatively affect cancer treatment outcomes, though every situation is individual. This needs to be confirmed with your oncology team.

How long can frozen eggs be stored? Vitrification technology means frozen eggs do not degrade with storage time. Pregnancies have been reported using eggs stored for more than a decade. Some countries have legal limits on storage duration. In the UK, for example, eggs can be stored for up to 55 years with appropriate consent renewal every 10 years. U.S. clinics have their own policies, so confirm storage terms with your clinic.

Does egg freezing affect my menstrual cycle long-term? No. The procedure affects only one cycle. Your period will typically return 12 to 14 days after egg retrieval, and the process has no long-term impact on your cycle.

What are my options if egg freezing isn’t possible? If both ovaries are removed or egg freezing wasn’t possible before treatment, options for future parenthood still exist. IVF with donor eggs, embryo adoption, and surrogacy are all paths worth discussing with a specialist. These are not second-best options. Many women have built their families through them.

Can I get pregnant naturally after ovarian cancer treatment? It depends on the extent of surgery and the impact of treatment on your remaining ovarian tissue. Some women with fertility-sparing surgery and preserved ovarian function do conceive naturally. This is something your gynecologic oncologist can speak to based on your specific situation. For more on this topic, our guide to ovarian cancer and pregnancy covers the topic in depth.

The Bigger Picture

A cancer diagnosis brings with it a lot of things you didn’t choose. Oocyte cryopreservation is one area where you can take action. Doing so before treatment begins, if at all possible, gives you the best chance of keeping your options open.

Talk to your oncologist about a referral to a reproductive endocrinologist as early as possible. Even if you’re not certain you want children, understanding what’s available can make a meaningful difference in how you feel about what comes next.